News
Brokers who abandon self-service links and generic emails in favor of concierge-level installation and education will see ...
Clinicians and scientists from RWJBarnabas Health and Rutgers Cancer Institute will share new findings and lead discussions ...
The poster will feature Rakuten Medical's ongoing ... The ASP-1929-381 study is a multi-regional multi-center, randomized, open-label Phase 3 trial, designed to assess the efficacy and safety ...
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that an abstract of the research results of the confirmatory ...
Detailed price information for Nuvation Bio Inc (NUVB-N) from The Globe and Mail including charting and trades.
The National Academies of Sciences, Engineering, and Medicine are the nation's pre-eminent source of high-quality, objective advice on science, engineering, and health matters ... of NAS Explore PNAS ...
They cost more but also pay for more of your dental bills, so you pay less for dental care ... can do this on HealthCare.gov or your state's health insurance marketplace site. Even if you just need a ...
SAN DIEGO, May 22, 2025 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox™ platform-based photoimmunotherapy, today announced that it will ...
As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results